Lokken Investment Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$3.12M Sell
4,090
-1,329
-25% -$989K 1.07% 24
2025
Q2
$4.22M Sell
5,419
-197
-4% -$153K 1.63% 18
2025
Q1
$4.64M Buy
5,616
+1,510
+37% +$1.26M 1.96% 16
2024
Q4
$3.17M Sell
4,106
-63
-2% -$52.2K 1.37% 18
2024
Q3
$3.69M Sell
4,169
-30
-0.7% -$27K 1.54% 17
2024
Q2
$3.8M Sell
4,199
-337
-7% -$270K 1.79% 15
2024
Q1
$3.53M Sell
4,536
-224
-5% -$159K 1.76% 15
2023
Q4
$2.77M Hold
4,760
1.57% 15
2023
Q3
$2.56M Sell
4,760
-4
-0.1% -$2.06K 1.68% 15
2023
Q2
$2.23M Sell
4,764
-153
-3% -$64.2K 1.46% 18
2023
Q1
$1.69M Sell
4,917
-95
-2% -$32K 1.28% 19
2022
Q4
$1.83M Buy
5,012
+71
+1% +$25.2K 1.45% 20
2022
Q3
$1.6M Buy
4,941
+1
+0% +$317 1.38% 22
2022
Q2
$1.6M Sell
4,940
-106
-2% -$31.8K 1.3% 20
2022
Q1
$1.47M Buy
5,046
+40
+0.8% +$10.3K 1.17% 22
2021
Q4
$1.38M Buy
5,006
+388
+8% +$98.4K 0.99% 24
2021
Q3
$1.07M Sell
4,618
-124
-3% -$30.6K 0.85% 28
2021
Q2
$1.09M Buy
4,742
+1
+0% +$201 0.88% 27
2021
Q1
$886K Sell
4,741
-419
-8% -$82K 0.78% 31
2020
Q4
$871K Buy
+5,160
New +$770K 0.8% 28

Other funds holding LLY

Lokken Investment Group's LLY Position: Q3 2025 in Review

Lokken Investment Group reduced its Eli Lilly (LLY) stake by 25% in Q3 2025, selling an estimated $989K and leaving 4,090 shares worth $3.12M. The position accounts for 1.07% of the portfolio, ranked #24.

Lokken Investment Group first reported a position in LLY in Q4 2020 and has held it in 20 quarters since. The position peaked at $4.64M in Q1 2025. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Lokken Investment Group held 4,090 shares of Eli Lilly worth $3.12M as of Q3 2025.
  • Lokken Investment Group sold 1,329 Eli Lilly shares in Q3 2025, an estimated $989K.
  • Eli Lilly made up 1.07% of Lokken Investment Group's portfolio in Q3 2025, its #24 holding.
  • Lokken Investment Group first reported a position in Eli Lilly in Q4 2020 and has held it in 20 quarters since.
  • Lokken Investment Group's Eli Lilly position peaked at $4.64M in Q1 2025.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Lokken Investment Group's 13F filing for Q3 2025, filed 5 Nov 2025.